• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对冠状动脉分叉病变经皮冠状动脉介入治疗长期预后的影响。

Impact of Diabetes on Long-Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions.

作者信息

Lim Subin, Hong Soon Jun, Kim Ju Hyeon, Cha Jung-Joon, Joo Hyung Joon, Park Jae Hyoung, Yu Cheol Woong, Lim Do-Sun, Nam Chang-Wook

机构信息

Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.

出版信息

Catheter Cardiovasc Interv. 2025 Aug;106(2):743-751. doi: 10.1002/ccd.31476. Epub 2025 Mar 5.

DOI:10.1002/ccd.31476
PMID:40045508
Abstract

BACKGROUND

Diabetes mellitus (DM) is a well-known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.

AIMS

The effect of DM on cardiovascular outcomes in bifurcation PCI was investigated in this retrospective, multicenter, observational, real-world registry of 2648 patients with coronary bifurcation lesions undergoing PCI with contemporary drug-eluting stents (DES).

METHODS

The primary outcome was target lesion failure (TLF), defined as a composite of cardiac death, target vessel myocardial infarction and target lesion revascularization. The adjusted outcomes were compared using 1:1 propensity score (PS) matching.

RESULTS

Overall, DM patients were more likely to be older, female, and have hypertension or chronic kidney disease. After PS matching, the cumulative incidence of the primary outcome remained higher in the DM group (7.9% vs. 5.5%, log-rank p = 0.033). In multivariable analysis, DM (HR, 1.57; 95% CI, 1.02-2.43; p = 0.040), chronic kidney disease (HR, 2.62; 95% CI, 1.27-5.38; p = 0.008), low left ventricular ejection fraction (HR, 1.92; 95% CI, 1.10-3.35; p = 0.022) and the two-stent technique (HR, 2.18; 95% CI, 1.17-4.05; p = 0.013) were independent predictors of TLF. For patients with intravascular ultrasound-guided PCI, TLF rates were similar between DM and non-DM groups (9.1% vs. 7.3%, log-rank p = 0.347).

CONCLUSION

For patients with coronary bifurcation lesions undergoing contemporary PCI, 5-year TLF rates were worse in DM patients. Careful planning and usage of imaging devices may help ameliorate outcomes for DM patients.

摘要

背景

糖尿病(DM)是包括冠状动脉疾病(CAD)在内的心血管疾病的一个众所周知的危险因素。复杂的经皮冠状动脉介入治疗(PCI),如分叉病变的PCI,往往效果不佳,尤其是在糖尿病患者中。

目的

在这项回顾性、多中心、观察性、真实世界的注册研究中,对2648例接受当代药物洗脱支架(DES)PCI的冠状动脉分叉病变患者进行了研究,以探讨糖尿病对分叉病变PCI心血管结局的影响。

方法

主要结局为靶病变失败(TLF),定义为心源性死亡、靶血管心肌梗死和靶病变血运重建的复合结局。使用1:1倾向评分(PS)匹配比较调整后的结局。

结果

总体而言,糖尿病患者更可能年龄较大、为女性,且患有高血压或慢性肾脏病。PS匹配后,糖尿病组主要结局的累积发生率仍然较高(7.9%对5.5%,对数秩p = 0.033)。在多变量分析中,糖尿病(HR,1.57;95%CI,1.02 - 2.43;p = 0.040)、慢性肾脏病(HR,2.62;95%CI,1.27 - 5.38;p = 0.008)、低左心室射血分数(HR,1.92;95%CI,1.10 - 3.35;p = 0.022)和双支架技术(HR,2.18;95%CI,1.17 - 4.05;p = 0.013)是TLF的独立预测因素。对于血管内超声引导下PCI的患者,糖尿病组和非糖尿病组的TLF率相似(9.1%对7.3%,对数秩p = 0.347)。

结论

对于接受当代PCI的冠状动脉分叉病变患者,糖尿病患者的5年TLF率更差。仔细规划和使用成像设备可能有助于改善糖尿病患者的结局。

相似文献

1
Impact of Diabetes on Long-Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions.糖尿病对冠状动脉分叉病变经皮冠状动脉介入治疗长期预后的影响。
Catheter Cardiovasc Interv. 2025 Aug;106(2):743-751. doi: 10.1002/ccd.31476. Epub 2025 Mar 5.
2
Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions.药物涂层球囊经皮冠状动脉介入治疗治疗初发型病变后靶病变失败的预测因素。
EuroIntervention. 2024 Jul 1;20(13):e818-e825. doi: 10.4244/EIJ-D-23-01006.
3
Intravascular Imaging-Guided Versus Angiography-Guided Complex PCI in Patients With High Bleeding Risk: A Secondary Analysis of the RENOVATE-COMPLEX PCI Trial.高出血风险患者血管内成像引导与血管造影引导下的复杂经皮冠状动脉介入治疗:RENOVATE-COMPLEX PCI试验的二次分析
Circ Cardiovasc Interv. 2025 Mar;18(3):e014952. doi: 10.1161/CIRCINTERVENTIONS.124.014952. Epub 2025 Mar 18.
4
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
5
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction.急性心肌梗死患者中 Cilotax 双药物洗脱支架与依维莫司洗脱支架的 3 年临床结果。
Tex Heart Inst J. 2024 May 1;51(1). doi: 10.14503/THIJ-23-8271.
6
Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.治疗真性左主干冠状动脉分叉病变的逐步临时与系统性双支架策略
Circulation. 2025 Mar 4;151(9):612-622. doi: 10.1161/CIRCULATIONAHA.124.071153. Epub 2025 Feb 5.
7
Transradial Versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stent.经桡动脉入路与经股动脉入路在第二代药物洗脱支架分叉经皮冠状动脉介入治疗中的应用比较。
J Korean Med Sci. 2024 Mar 18;39(10):e111. doi: 10.3346/jkms.2024.39.e111.
8
Validation of complex PCI criteria in drug-coated balloon angioplasty.药物涂层球囊血管成形术中复杂经皮冠状动脉介入治疗标准的验证
Clin Res Cardiol. 2025 May 19. doi: 10.1007/s00392-025-02664-x.
9
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.左主干冠状动脉狭窄:药物洗脱支架与冠状动脉旁路移植术的荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1219-30. doi: 10.1016/j.jcin.2013.07.008.
10
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.

本文引用的文献

1
Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.经心尖植入 Impella 支持高危经皮冠状动脉介入治疗的慢性肾脏病患者的血管造影特征和临床结局:来自 cVAD PROTECT III 研究的见解。
Circ Cardiovasc Interv. 2024 Jul;17(7):e013503. doi: 10.1161/CIRCINTERVENTIONS.123.013503. Epub 2024 May 6.
2
Comparison of Atherosclerotic Plaque Compositions in Diabetic and Non-diabetic Patients.糖尿病患者与非糖尿病患者动脉粥样硬化斑块成分的比较。
Cureus. 2023 Sep 21;15(9):e45721. doi: 10.7759/cureus.45721. eCollection 2023 Sep.
3
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南
Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.
4
Intravascular Imaging-Guided or Angiography-Guided Complex PCI.血管内影像学指导或血管造影指导下的复杂 PCI。
N Engl J Med. 2023 May 4;388(18):1668-1679. doi: 10.1056/NEJMoa2216607. Epub 2023 Mar 5.
5
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.复杂经皮冠状动脉介入治疗特征对合并或不合并慢性肾脏病患者临床结局的影响。
Catheter Cardiovasc Interv. 2023 Feb;101(3):511-519. doi: 10.1002/ccd.30569. Epub 2023 Jan 24.
6
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.缺血性左心室功能障碍的经皮血管重建术。
N Engl J Med. 2022 Oct 13;387(15):1351-1360. doi: 10.1056/NEJMoa2206606. Epub 2022 Aug 27.
7
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.沙库巴曲缬沙坦对合并糖尿病的心衰患者血糖的影响:PARAGON-HF 和 PARADIGM-HF 试验。
Cardiovasc Diabetol. 2022 Jun 18;21(1):110. doi: 10.1186/s12933-022-01545-1.
8
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.糖尿病患者支架内再狭窄的发病机制及临床意义。
Int J Environ Res Public Health. 2021 Nov 15;18(22):11970. doi: 10.3390/ijerph182211970.
9
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.Amphilimus- 与 zotarolimus- 洗脱支架在合并糖尿病的冠状动脉疾病患者中的应用:SUGAR 试验。
Eur Heart J. 2022 Mar 31;43(13):1320-1330. doi: 10.1093/eurheartj/ehab790.
10
Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention.药物洗脱支架在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死糖尿病患者中的疗效
J Cardiovasc Dev Dis. 2021 Jul 21;8(8):83. doi: 10.3390/jcdd8080083.